Dicerna To Present At Two November Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leading developer of RNA interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present at the following conferences:

• Stifel 2015 Healthcare Conference. Dicerna’s presentation will take place on Tuesday, November 17, 2015 at 1:30 p.m. EST at The New York Palace Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.

Back to news